Canada Drug Agency Recommends Public Coverage for Lilly Alzheimer’s Drug
Canada's Drug Agency recommended that public drug plans reimburse Eli Lilly's Kisunla Alzheimer’s treatment.
Related stories
US Flights to Resume After Air Traffic Network Failure
US flights are set to resume after an air traffic network failure disrupted operations.
M impact | EQUITY | Nov 14, 2026, 08:06 AM UTC
UniCredit Raises $3.5 Billion
M impact | EQUITY | Nov 14, 2026, 08:03 AM UTC
AMAT Shares Fall 2.58% as Headline Cites Record Q4 Revenue
The headline also says 2027 demand is seen above 30%, but provides no further context.
M impact | EQUITY | Nov 14, 2026, 08:02 AM UTC
MSCI to Drop MSTR; CEO Sees Low Impact; $6.8B Bitcoin Loss
M impact | EQUITY | Nov 14, 2026, 08:02 AM UTC
IndiGo Says Global Microsoft Service Disruption Is Fully Resolved
IndiGo said a global Microsoft service disruption affecting its email support services has been fully resolved.
M impact | EQUITY | Nov 14, 2026, 07:36 AM UTC
FAA Tech Failure Grounds Flights for Nearly Five Hours
Air travel ground to a halt for almost five hours Friday after an overloaded air traffic control system failed, snarling operations at Sea-Tac.
M impact | EQUITY | Nov 14, 2026, 07:32 AM UTC